检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:袁宗[1] 陶克[1] 谢松涛[1] 侯宏义[1] 胡大海[1]
机构地区:[1]第四军医大学西京医院烧伤与皮肤外科,西安710032
出 处:《中国医师杂志》2017年第5期647-649,共3页Journal of Chinese Physician
摘 要:目的研究负压封闭引流(VSD)技术对瘢痕松解一期植皮与二期植皮疗效的差异。方法将42例欲行瘢痕松解植皮手术的患者随机分为对照组和负压组,每组21例。对照组实施瘢痕松解后一期皮肤移植,负压组实施瘢痕松解后VSD治疗创面3d再行二期皮肤移植,观察植皮术后7d皮下淤血率和植皮成活率以及术后半年移植皮肤挛缩增生情况。结果术后7d负压组皮下淤血发生率明显低于对照组(P〈0.05),植皮成活率显著高于对照组(P〈0.05);术后半年负压组移植皮肤温哥华瘢痕评分显著低于对照组(P〈0.05)。结论瘢痕松解负压治疗二期植皮较一期植皮可降低皮下淤血发生,促进植皮成活,减轻术后移植皮片挛缩,改善患者预后。Objective To investigate the difference of vacuum sealing drainage (VSD) on the effect of one-stage skin graft and second-stage sugery after scar release. Methods A total of 42 patients who wanted to undergo scar release and skin graft was randomly divided to control group ( n = 21 ) and VSD treatment group ( n = 21 ). The control group implemented skin graft immdiately after scar release while VSD treatment group were treated with VSD for 3 days after scar release and then implemented skin graft. The rate of subcutaneous blood stasis and the survival rate of skin graft were observed at 7 days after skin graft. The condition of grafted skin contraeture and hyperplasia after half a year was also observed. Results The incidence of subcutaneous blood stasis was significantly lower in the VSD group than that in the control group (P 〈 0. 05). The survival rate of skin grafts was significantly higher in the VSD group than that of the control group ( P 〈 0. 05 ). The score of Vancouver scar was significantly lower in the VSD group than that in the control group (P 〈 0. 05). Conclusions VSD treatment of second-stage sugery after scar release can reduce the occurrence of subcutaneous blood stasis, promote skin graft survival, reduce postoperative skin graft contracture and improve the prognosis of patients compared to one-stage skin graft.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.117